Huagai Capital Leads $60M Series A Round In Chinese Biological Medicine Start-up

Chinese biological medicine start-up JOINN Biologics has raised US$60 million in a series A round of financing led by the country’s private equity investment firm Huagai Capital.

China Money Network

UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech


Register Now

Want to read this important story?

Access thousands of news articles and data posts over the past 9 years!


Already have an account or paid subscription? Log in

Caishen.Co - Primary Data for China Secondary Investment and Stock Markets

LEAVE A REPLY